Literature DB >> 2501347

Wound infection caused by Branhamella catarrhalis.

L D Gray1, R E Van Scoy, J P Anhalt, P K Yu.   

Abstract

Branhamella catarrhalis was isolated from sputum, tracheal secretions, and a nonhealing and infected thoracic surgical wound in a 59-year-old woman who had a history of a chronic, interstitial fibrosis and who had undergone an open lung biopsy procedure. The patient's upper respiratory tract was the likely source of the organism. To our knowledge, this is the first report of a wound infection caused by B. catarrhalis.

Entities:  

Mesh:

Year:  1989        PMID: 2501347      PMCID: PMC267435          DOI: 10.1128/jcm.27.5.818-820.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

Review 1.  Branhamella catarrhalis--an emerging human pathogen.

Authors:  G V Doern
Journal:  Diagn Microbiol Infect Dis       Date:  1986-03       Impact factor: 2.803

2.  In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.

Authors:  S Alvarez; M Jones; S Holtsclaw-Berk; J Guarderas; S L Berk
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

3.  A case of acute catarrhal conjunctivitis due to Branhamella catarrhalis.

Authors:  Y Kawakami; K Segawa; M Kanai
Journal:  Microbiol Immunol       Date:  1983       Impact factor: 1.955

4.  beta-Lactamase-producing Branhamella catarrhalis causing otitis media in children.

Authors:  A L Kovatch; E R Wald; R H Michaels
Journal:  J Pediatr       Date:  1983-02       Impact factor: 4.406

5.  Branhamella catarrhalis cellulitis around a cerebrospinal fluid shunt: case report.

Authors:  B A Kaufman; M J Likavec
Journal:  J Hosp Infect       Date:  1985-09       Impact factor: 3.926

6.  Branhamella catarrhalis septic arthritis.

Authors:  D B Craig; P A Wehrle
Journal:  J Rheumatol       Date:  1983-12       Impact factor: 4.666

7.  Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases.

Authors:  E E Stobberingh; B I Davies; C P van Boven
Journal:  J Antimicrob Chemother       Date:  1984-01       Impact factor: 5.790

8.  Acute otitis media caused by Branhamella catarrhalis: biology and therapy.

Authors:  G F Van Hare; P A Shurin; C D Marchant; N A Cartelli; C E Johnson; D Fulton; S Carlin; C H Kim
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

9.  Branhamella catarrhalis pneumonia: report of two cases and review of the literature.

Authors:  G Srinivasan; M J Raff; W C Templeton; S J Givens; R C Graves; J C Melo
Journal:  Am Rev Respir Dis       Date:  1981-05

Review 10.  Branhamella catarrhalis respiratory infections.

Authors:  H Hager; A Verghese; S Alvarez; S L Berk
Journal:  Rev Infect Dis       Date:  1987 Nov-Dec
View more
  6 in total

1.  Evaluation of Bacto TB hydrolysis reagent (Tween 80) for the identification of Branhamella catarrhalis.

Authors:  M Weiner; P D Penha
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

Review 2.  Lung infections. 2. Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen.

Authors:  T F Murphy
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

Review 3.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

Review 4.  Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

Authors:  T F Murphy
Journal:  Microbiol Rev       Date:  1996-06

5.  Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis.

Authors:  J Sarwar; A A Campagnari; C Kirkham; T F Murphy
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  Pneumonia caused by Moraxella catarrhalis in haematopoietic stem cell transplant patients. Report of two cases and review of the literature.

Authors:  Ka Al-Anazi; Fa Al-Fraih; Na Chaudhri; Fi Al-Mohareb
Journal:  Libyan J Med       Date:  2007-09-01       Impact factor: 1.657

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.